Honorary Professor Geoffrey Hill
Honorary Professor

Geoffrey Hill

Email: 

Background

Professor Geoff Hill MBChB MD BHB FRCPA FRACP geoffH@qimr.edu.au

NHMRC Australia and QLD Health Senior Clinical Research Fellow

Coordinator, Cancer Programme, QIMR Berghofer

Head, Bone Marrow Transplantation Laboratory, QIMR Berghofer

Director of Research, Cancer Care Services, Royal Brisbane & Womens’ Hospital

Bone Marrow Transplant Physician and Haematologist, Royal Brisbane & Womens’ Hospital

Geoff Hill is a medical graduate of the University of Auckland and Haematologist, training in New Zealand, The Dana Farber Cancer Institute in Boston. He is a NHMRC Australia Fellow and his immunology laboratory focuses on the interactions between cytokines, antigen presenting cells and regulatory T cells during transplantation.

Professor Hill was the 2005 Queenslander of the Year and recipient of the Transplantation Society of Australia and New Zealand 2009 Ian McKenzie Award and the 2014 Translational Research Institute National Prize for excellence within basic and clinical research in the transplant field. He was also awarded a Queensland Health Senior Clinical Research Fellowship in 2010 to translate new cytokine and cell based therapies into clinic practice.

Availability

Honorary Professor Geoffrey Hill is:
Available for supervision

Fields of research

Clinical sciences Immunology

Qualifications

  • Bachelor, The University of Auckland
  • Masters (Coursework) of Medicine Surgery, The University of Auckland
  • Doctoral Diploma of Medicine, The University of Auckland
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia

Search Professor Geoffrey Hill’s works on UQ eSpace

277 works between 1996 and 2024
All (277) Journal Article (249) Book Chapter (2) Conference Publication (26)

261 - 277 of 277 works

1999

Journal Article

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation

Teshima, T, Hill, GR, Pan, LY, Brinson, YS, van den Brink, MRM, Cooke, KR and Ferrara, JLM (1999). IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. Journal of Clinical Investigation, 104 (3), 317-325. doi: 10.1172/JCI7111

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation

1999

Journal Article

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

Hill, GR, Teshima, T, Gerbitz, A, Pan, LY, Cooke, KR, Brinson, YS, Crawford, JM and Ferrara, JLM (1999). Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. Journal of Clinical Investigation, 104 (4), 459-467. doi: 10.1172/JCI6896

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1999

Journal Article

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

Krijanovski, OI, Hill, GR, Cooke, KR, Teshima, T, Crawford, JM, Brinson, YS and Ferrara, JLM (1999). Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood, 94 (2), 825-831.

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1999

Journal Article

Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation

Hill, GR, Cooke, KR, Brinson, YS, Bungard, D and Ferrara, JLM (1999). Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation, 67 (11), 1478-1480. doi: 10.1097/00007890-199906150-00015

Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation

1999

Journal Article

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease

Pan, LP, Teshima, T, Hill, GR, Bungard, D, Brinson, YS, Reddy, VS, Cooke, KR and Ferrara, LM (1999). Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood, 93 (12), 4071-4078.

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease

1999

Journal Article

Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma

Hart, D. N. J. and Hill, G. R. (1999). Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma. Immunology and Cell Biology, 77 (5), 451-459. doi: 10.1046/j.1440-1711.1999.00859.x

Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma

1998

Journal Article

Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder

Wickramashinghe, SN, Spearing, RL and Hill, GR (1998). Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder. British Journal of Haematology, 103 (3), 831-834.

Congenital dyserythropoiesis with intererythroblastic chromatin bridges and ultrastructurally-normal erythroblast heterochromatin: a new disorder

1998

Journal Article

Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

Cooke, KR, Hill, GR, Crawford, JM, Bungard, D, Brinson, YS, Delmonte, J and Ferrara, JLM (1998). Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. Journal of Clinical Investigation, 102 (10), 1882-1891. doi: 10.1172/JCI4285

Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

1998

Journal Article

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation

Hill, GR, Cooke, KR, Teshima, T, Crawford, JM, Keith, JC, Brinson, YS, Bungard, D and Ferrara, JLM (1998). Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Clinical Investigation, 102 (1), 115-123. doi: 10.1172/JCI3132

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation

1997

Journal Article

The role of cytokines in acute graft-versus-host disease

Hill, GR, Krenger, W and Ferrara, JLM (1997). The role of cytokines in acute graft-versus-host disease. Cytokines Cellular & Molecular Therapy, 3 (4), 257-265.

The role of cytokines in acute graft-versus-host disease

1997

Journal Article

Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines

Hill, GR, Crawford, JM, Cooke, KR, Brinson, YS, Pan, LY and Ferrara, JLM (1997). Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood, 90 (8), 3204-3213.

Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines

1997

Journal Article

Cytokine cascades in acute graft-versus-host disease

Krenger, W, Hill, GR and Ferrara, JLM (1997). Cytokine cascades in acute graft-versus-host disease. Transplantation, 64 (4), 553-558. doi: 10.1097/00007890-199708270-00001

Cytokine cascades in acute graft-versus-host disease

1997

Journal Article

The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations

Hill, GR, Hickton, C, Henderson, S and Patton, WN (1997). The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations. Clinical and Laboratory Haematology, 19 (2), 155-157. doi: 10.1046/j.1365-2257.1997.00052.x

The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations

1996

Journal Article

Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia

Hill, G, McClean, D, Fraser, R, Hart, D, Crozier, , Snowden, J and Gibbons, S (1996). Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia. Australian and New Zealand Journal of Medicine, 26 (6), 852-853. doi: 10.1111/j.1445-5994.1996.tb00642.x

Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia

1996

Journal Article

Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review

Hill, GR, Hickton, CM, Brennan, SO, Atkinson, CH and Heaton, DC (1996). Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review. Clinical and Laboratory Haematology, 18 (4), 291-295.

Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review

1996

Journal Article

High dose therapy and autologous bone marrow versus blood cell rescue

Hill, GR, Inder, A and Patton, WN (1996). High dose therapy and autologous bone marrow versus blood cell rescue. New Zealand Medical Journal, 109 (1016), 45-48.

High dose therapy and autologous bone marrow versus blood cell rescue

1996

Journal Article

Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation

Hill, GR, Hart, DNJ, Moore, AF and Morris, CM (1996). Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation. Pathology, 28 (1), 51-53. doi: 10.1080/00313029600169523

Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation

Current funding

  • 2024 - 2027
    Harnessing the gut microbiome to improve stem cell transplant outcome (NHMRC Ideas 2023 Administered by The Council of the Queensland Institute of Medical Research)
    Queensland Institute of Medical Research
    Open grant

Past funding

  • 2015 - 2016
    Developing new ways to predict infection in patients undergoing chemotherapy and bone marrow transplantation
    UQ Academic Title Holder Research Fund
    Open grant
  • 2010 - 2014
    Immunological therapies for cancer, chronic infection and autoimmunity
    NHMRC Program Grant
    Open grant
  • 2005 - 2009
    Immunological therapies for cancer and autoimmunity
    NHMRC Program Grant
    Open grant
  • 2003 - 2004
    Migration And Differentiation Of Dendritic Cells And Monocytes In Inflammatory Arthritis
    NHMRC Project Grant
    Open grant

Availability

Honorary Professor Geoffrey Hill is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Honorary Professor Geoffrey Hill's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au